|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/166 | |
| A61K 9/08 | |||
| A61K 31/14 | |||
| A61P 1/08 | |||
| A61K 9/00 | |||
| A61K 47/12 |
| (11) | Number of the document | 2376075 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09835796.5 |
| Date of filing the European patent application | 2009-12-22 | |
| (97) | Date of publication of the European application | 2011-10-19 |
| (45) | Date of publication and mention of the grant of the patent | 2015-04-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/069298 |
| Date | 2009-12-22 |
| (87) | Number | WO 2010/075444 |
| Date | 2010-07-01 |
| (30) | Number | Date | Country code |
| 140034 P | 2008-12-22 | US |
| (72) |
D`ONOFRIO, Matthew, J., US
GONYER, David, A., US
SHAH, Shirish, A., US
MADDEN, Stuart, J., US
|
| (73) |
Evoke Pharma, Inc.,
505 Lomas Santa Fe Drive, Suite 270, Solana Beach, CA 92075,
US
|
| (54) | NASAL FORMULATIONS OF METOCLOPRAMIDE |
| NASAL FORMULATIONS OF METOCLOPRAMIDE |